<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46-genes-12-00257">
 <label>46.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Creighton</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Massarweh</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tsimelzon</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hilsenbeck</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Osborne</surname>
    <given-names>C.K.</given-names>
   </name>
   <name>
    <surname>Shou</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Malorni</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Schiff</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts</article-title>
  <source>Cancer Res.</source>
  <year>2008</year>
  <volume>68</volume>
  <fpage>7493</fpage>
  <lpage>7501</lpage>
  <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-1404</pub-id>
  <pub-id pub-id-type="pmid">18794137</pub-id>
 </element-citation>
</ref>
